Browsing Category
Pharma Industry News
4743 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
KouShiCare unveils DWV light therapy breakthrough with LuminEyes device for dry eye treatment
KouShiCare launches the LuminEyes Light Therapy Device using DWV LLLT to treat dry eye disease through home-use red light therapy.
Elpis Biopharmaceuticals signs cell therapy research pact with National Cancer Centre Singapore to advance armored CAR-T innovation
Elpis Biopharmaceuticals signs MOU with Singapore’s NCCS to advance armored CAR-T cell therapy research for solid tumors, targeting rapid clinical translation
Sun Nuclear to unveil AI-driven radiation therapy QA tools and detectors at AAPM 2025
Sun Nuclear will debut adaptive QA software, AI-based planning tools, and new dosimetry detectors at AAPM 2025, aiming to enhance precision and safety in radiotherapy.
Ascletis doses first obesity patients in U.S. Phase IIa trial of once-monthly GLP-1R depot ASC30
Ascletis (HKEX: 1672) begins dosing in U.S. Phase IIa obesity trial of ASC30, its once-monthly small molecule GLP-1R agonist, with topline data expected Q1 2026.
Jagsonpal Pharmaceuticals Q1 FY26 results: Can sustained brand momentum and strong cash flows drive further growth in India’s domestic market?
Jagsonpal Pharmaceuticals’ Q1 FY26 revenue rose 23% YoY to ₹756M, with PAT doubling to ₹108M. Can strong cash flows fuel future inorganic growth?
Stablepharma’s fridge-free vaccine breakthrough: Dr Karen O’Hanlon explains the StablevaX journey
Find out how Stablepharma’s SPVX02 could redefine global vaccine logistics with fridge-free technology. Dr Karen O’Hanlon explains the science behind StablevaX™.
Alembic Pharmaceuticals gains three USFDA approvals in oncology and neurology, but can these launches offset U.S. pricing pressures?
Alembic Pharmaceuticals secures USFDA approvals in oncology and neurology, but can these launches drive U.S. revenue growth? Read the full analysis.
Shanton Pharma’s SAP-001 earns FDA Fast Track status for refractory gout treatment
FDA grants Fast Track designation to Shanton Pharma’s SAP-001 for refractory gout; company plans accelerated development and Phase 3 trials.
Can Sanofi’s molecular clamp bet with Vicebio challenge mRNA leaders in respiratory vaccines?
Can Sanofi’s $1.15B Vicebio deal challenge Pfizer and Moderna’s mRNA RSV dominance? Explore how molecular clamp vaccines could change respiratory protection.
Can faster CAR-T turnaround save more lives under the UK’s new point-of-care manufacturing rules?
The UK’s new point-of-care rules promise faster CAR-T therapy turnaround—find out how this could improve cancer survival rates and expand NHS access.